Literature DB >> 827289

Glycogen phosphorylase, glucose output and vasoconstriction in the perfused rat liver. Concentration-dependence of actions of adrenaline, vasopressin and angiotensin II.

D A Hems, L M Rodrigues, P D Whitton.   

Abstract

1. Glycogen phosphorylase (a form, in rapidly freeze-clamped samples) and glucose release were measured in the perfused liver, in response to a range of concentrations of adrenaline, [8-arginine]vasopressin (anti-diuretic hormone) and angiotensin II. 2. All three hormones increased phosphorylase a activity by about 10 mumol/min per g of fresh liver, which was more than sufficient to explain concomitant glucose release (1-2mumol/min per g). 3. Minimally effective concentrations which activated phosphorylase were: adrenaline, 10nM (2ng/ml); vasopressin, 40pM (40pg/ml, 15 muunits/ml); angiotensin II, 60pM (60pg/ml). 4. Glycogen synthase activity was inhibited by adrenaline and vasopressin but not significantly by angiotensin II. 5. Vasoconstriction observed with adrenaline and angiotensin II (but not vasopressin) might explain part of the activation of phosphorylase, since equivalent vasoconstriction (in separate perfusions) activated phosphorylase, did not stimulate glucose output or inhibit synthase. 6. The potency of these effects suggests that all three hormones can stimulate hepatic glycogen degradation in vivo (by direct hepatic action). It is proposed that hormones, and ischaemia, stimulate glycogen degradation to provide glucose phosphates for disposal within the liver cell, as well as for release as free gluose.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 827289      PMCID: PMC1164243          DOI: 10.1042/bj1600367

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  52 in total

1.  ANGIOTENSIN BLOOD LEVELS IN HEMORRHAGIC HYPOTENSION AND OTHER RELATED CONDITIONS.

Authors:  O A SCORNIK; A C PALADINI
Journal:  Am J Physiol       Date:  1964-03

2.  A SENSITIVE METHOD FOR THE ASSAY OF ANGIOTENSIN.

Authors:  D REGOLI; J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1964-10

3.  ACTIVATION OF PHOSPHORYLASE IN TOAD BLADDER AND MAMMALIAN KIDNEY BY ANTIDIURETIC HORMONE.

Authors:  J S HANDLER; J ORLOFF
Journal:  Am J Physiol       Date:  1963-08

4.  The effects of hypoglycemia on the adrenal secretion of epinephrine and norepinephrine in the dog.

Authors:  A GOLDFIEN; M S ZILELI; R H DESPOINTES; J E BETHUNE
Journal:  Endocrinology       Date:  1958-06       Impact factor: 4.736

5.  The sequential inactivation of glycogen phosphorylase and activation of glycogen synthetase in liver after the administration of glucose to mice and rats. The mechanism of the hepatic threshold to glucose.

Authors:  W Stalmans; H De Wulf; L Hue; H G Hers
Journal:  Eur J Biochem       Date:  1974-01-03

Review 6.  The endocrine response to trauma.

Authors:  I D Johnston
Journal:  Adv Clin Chem       Date:  1972       Impact factor: 5.394

7.  Glycogen synthetase and phosphorylase activities in different tissues of genetically obese mice.

Authors:  I Das; D A Hems
Journal:  Horm Metab Res       Date:  1974-01       Impact factor: 2.936

8.  Stimulation by vasopressin of glycogen breakdown and gluconeogenesis in the perfused rat liver.

Authors:  D A Hems; P D Whitton
Journal:  Biochem J       Date:  1973-11       Impact factor: 3.857

9.  The receptors concerned in the actions of catecholamines on glucose release, membrane potential and ion movements in guinea-pig liver.

Authors:  D G Haylett; D H Jenkinson
Journal:  J Physiol       Date:  1972-09       Impact factor: 5.182

10.  Sequential responses of the renin-angiotensin-aldosterone axis to acute postural change: effect of dietary sodium.

Authors:  M L Tuck; R G Dluhy; G H Williams
Journal:  J Lab Clin Med       Date:  1975-11
View more
  17 in total

1.  Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic function.

Authors:  J Howl; T Ismail; A J Strain; C J Kirk; D Anderson; M Wheatley
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  The metabolic and endocrine effects of circulating catecholamines in fetal sheep.

Authors:  C T Jones; J W Ritchie
Journal:  J Physiol       Date:  1978-12       Impact factor: 5.182

3.  The influence of vasopressin and related peptides on glycogen phosphorylase activity and phosphatidylinositol metabolism in hepatocytes.

Authors:  C J Kirk; L M Rodrigues; D A Hems
Journal:  Biochem J       Date:  1979-02-15       Impact factor: 3.857

4.  The use of the perfused liver or hepatocyte suspensions for the study of hepatic function [proceedings].

Authors:  D A Hems; C J Kirk; P D Whitton
Journal:  J Physiol       Date:  1978-02       Impact factor: 5.182

5.  Activation of pyruvate dehydrogenase in the perfused rat liver by vasopressin.

Authors:  D A Hems; J G McCormack; R M Denton
Journal:  Biochem J       Date:  1978-11-15       Impact factor: 3.857

6.  Stimulation by vasopressin, angiotensin and oxytocin of gluconeogenesis in hepatocyte suspensions.

Authors:  P D Whitton; L M Rodrigues; D A Hems
Journal:  Biochem J       Date:  1978-12-15       Impact factor: 3.857

7.  Glycogenolysis in liver of phosphorylase kinase-deficient rats during liver perfusion and ischaemia.

Authors:  G Lutaya; R J Sharma; J R Griffiths
Journal:  Biochem J       Date:  1983-08-15       Impact factor: 3.857

8.  Rapid stimulation by vasopressin, oxytocin and angiotensin II of glycogen degradation in hepatocyte suspensions.

Authors:  D A Hems; L M Rodrigues; P D Whitton
Journal:  Biochem J       Date:  1978-05-15       Impact factor: 3.857

9.  Metabolic effects of vasopressin infusion in the starved rat. Reversal of ketonaemia.

Authors:  A M Rofe; D H Williamson
Journal:  Biochem J       Date:  1983-04-15       Impact factor: 3.857

10.  The stimulation of glycogenolysis in isolated hepatocytes by opioid peptides.

Authors:  R P Leach; E H Allan; M A Titheradge
Journal:  Biochem J       Date:  1985-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.